NCT01467726 Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects Status COMPLETED Phase PHASE1
NCT01466088 Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD) Status COMPLETED Phase PHASE2
NCT01465360 Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center Status COMPLETED Phase N/A
NCT01459016 A Non-drug Methods Study in Participants With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT01454115 Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163 Status COMPLETED Phase PHASE1
NCT01447719 Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 Status COMPLETED Phase PHASE3
NCT01436045 Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. Status COMPLETED Phase PHASE2
NCT01428453 A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01424436 Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient Status COMPLETED Phase PHASE1
NCT01423396 Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease Status COMPLETED Phase NA
NCT01421056 Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP) Status COMPLETED Phase PHASE2
NCT01420315 The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's Disease Status COMPLETED Phase N/A
NCT01409915 Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01406145 A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil Status COMPLETED Phase PHASE1